Market Overview:
The global artificial cardiopulmonary machine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiac diseases and respiratory failures, rising geriatric population, and technological advancements in artificial cardiopulmonary machines. Based on type, the global artificial cardiopulmonary machine market is segmented into single roller pump HLM and double roller pump HLM. The single roller pump HLM segment is expected to account for the majority share of the global artificial cardiopulmonary machine market in 2018 owing to its low cost and easy maintenance. However, the double roller pump HLM segment is projected to grow at a higher CAGR during the forecast period due to its superior performance as compared with other types of pumps available in the market. Based on application,the global artificial cardiopulmonary machine market is divided into cardiac surgery, lung transplant operation, acute respiratory failure treatment, and others (including neonatal care).
Product Definition:
An artificial cardiopulmonary machine (ACPM) is a device that replaces or assists the functions of the heart and lungs. It is used to provide temporary support for patients in cardiac arrest, during surgery, or when their heart or lungs are not functioning properly. The ACPM helps to circulate blood and oxygen throughout the body, providing vital life-saving support until the patient's natural functions can resume.
Single Roller Pump HLM:
Single roller pump HLM is a low-volume, high-pressure pumping system that uses one or more rollers to transmit the fluid. The most common application of single roller pumps is in artificial cardiopulmonary machines (ACPMs). ACPMs are used for treating conditions such as cardiac arrest and pulmonary hypertension.
Double Roller Pump HLM:
Double roller pump HLM is a double acting hydraulic pump used in artificial cardiovascular machine. It's working principle is very simple, it takes two strokes to push fluid through the system and when both strokes are equal then the pressure in the circuit is 0. The main function of this device is to create pressure difference between left and right atria (upper chamber) so that blood can flow from right to left atrium (lower chamber).
Application Insights:
The others segment held the largest market share in 2017 and is anticipated to grow at a lucrative rate over the forecast period. This can be attributed to increasing number of patients suffering from cardiac arrest outside hospitals, rising adoption of advanced LAP-MCS devices by hospitals and healthcare facilities, availability of remote monitoring services for these machines across various regions.
The lung transplant operation segment is expected to witness significant growth during the forecast period owing to increase in prevalence of COPD and other respiratory diseases globally. According to estimates reported by WHO, approximately 65 million people suffer from COPD worldwide; however, only about 20% are receiving treatment due largely unavailability or shortage of appropriate ventilation equipment at home or in their place of residence. In addition, growing awareness regarding benefits associated with lung transplantation procedures coupled with high success rates witnessed for these procedures using modern artificial cardiopulmonary machines is expected fuel demand over the next few years.
Regional Analysis:
North America dominated the global artificial cardiopulmonary machine market in 2017. This can be attributed to increasing demand for technologically advanced products, high healthcare expenditure, and favorable reimbursement policies & regulatory reforms. The Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising patient awareness levels regarding heart diseases and cardiac surgeries along with improving healthcare infrastructure in this region. Moreover, growing medical tourism industry due to low procedural costs is also anticipated boost demand for these machines in this region during the forecast period.
The Asia Pacific was followed by Europe that accounted for a revenue share of around 27% in 2017 owing to an increase in research funding from public & private entities along with growing adoption of new technologies such as Artificial Intelligence (AI) & Machine Learning (ML). In addition, increasing R&D activities by various companies are contributing towards market growth across Europe as well as other regions including Latin America and MEA& Africa.
Growth Factors:
- Increasing prevalence of respiratory diseases and other cardiac disorders
- Growing geriatric population
- Rising demand for technologically advanced medical devices
- Increasing healthcare expenditure by governments and private players
- Technological advancements in the field of artificial cardiopulmonary machines
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Cardiopulmonary Machine Market Research Report
By Type
Single Roller Pump HLM, Double Roller Pump HLM
By Application
Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others
By Companies
LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Cardiopulmonary Machine Market Report Segments:
The global Artificial Cardiopulmonary Machine market is segmented on the basis of:
Types
Single Roller Pump HLM, Double Roller Pump HLM
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Tianjin Medical
Highlights of The Artificial Cardiopulmonary Machine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Roller Pump HLM
- Double Roller Pump HLM
- By Application:
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Cardiopulmonary Machine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial Cardiopulmonary Machine (ACPM) is a machine that helps the heart to pump blood.
Some of the major players in the artificial cardiopulmonary machine market are LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical.
The artificial cardiopulmonary machine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Cardiopulmonary Machine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Artificial Cardiopulmonary Machine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Artificial Cardiopulmonary Machine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Artificial Cardiopulmonary Machine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Artificial Cardiopulmonary Machine Market Size & Forecast, 2018-2028
4.5.1 Artificial Cardiopulmonary Machine Market Size and Y-o-Y Growth
4.5.2 Artificial Cardiopulmonary Machine Market Absolute $ Opportunity
Chapter 5 Global Artificial Cardiopulmonary Machine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Artificial Cardiopulmonary Machine Market Size Forecast by Type
5.2.1 Single Roller Pump HLM
5.2.2 Double Roller Pump HLM
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Artificial Cardiopulmonary Machine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Artificial Cardiopulmonary Machine Market Size Forecast by Applications
6.2.1 Cardiac Surgery
6.2.2 Lung Transplant Operation
6.2.3 Acute Respiratory Failure Treatment
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Cardiopulmonary Machine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Cardiopulmonary Machine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Artificial Cardiopulmonary Machine Analysis and Forecast
9.1 Introduction
9.2 North America Artificial Cardiopulmonary Machine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Artificial Cardiopulmonary Machine Market Size Forecast by Type
9.6.1 Single Roller Pump HLM
9.6.2 Double Roller Pump HLM
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Artificial Cardiopulmonary Machine Market Size Forecast by Applications
9.10.1 Cardiac Surgery
9.10.2 Lung Transplant Operation
9.10.3 Acute Respiratory Failure Treatment
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Artificial Cardiopulmonary Machine Analysis and Forecast
10.1 Introduction
10.2 Europe Artificial Cardiopulmonary Machine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Artificial Cardiopulmonary Machine Market Size Forecast by Type
10.6.1 Single Roller Pump HLM
10.6.2 Double Roller Pump HLM
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Artificial Cardiopulmonary Machine Market Size Forecast by Applications
10.10.1 Cardiac Surgery
10.10.2 Lung Transplant Operation
10.10.3 Acute Respiratory Failure Treatment
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Artificial Cardiopulmonary Machine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Artificial Cardiopulmonary Machine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Artificial Cardiopulmonary Machine Market Size Forecast by Type
11.6.1 Single Roller Pump HLM
11.6.2 Double Roller Pump HLM
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Artificial Cardiopulmonary Machine Market Size Forecast by Applications
11.10.1 Cardiac Surgery
11.10.2 Lung Transplant Operation
11.10.3 Acute Respiratory Failure Treatment
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Artificial Cardiopulmonary Machine Analysis and Forecast
12.1 Introduction
12.2 Latin America Artificial Cardiopulmonary Machine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Artificial Cardiopulmonary Machine Market Size Forecast by Type
12.6.1 Single Roller Pump HLM
12.6.2 Double Roller Pump HLM
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Artificial Cardiopulmonary Machine Market Size Forecast by Applications
12.10.1 Cardiac Surgery
12.10.2 Lung Transplant Operation
12.10.3 Acute Respiratory Failure Treatment
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Artificial Cardiopulmonary Machine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Artificial Cardiopulmonary Machine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Artificial Cardiopulmonary Machine Market Size Forecast by Type
13.6.1 Single Roller Pump HLM
13.6.2 Double Roller Pump HLM
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Artificial Cardiopulmonary Machine Market Size Forecast by Applications
13.10.1 Cardiac Surgery
13.10.2 Lung Transplant Operation
13.10.3 Acute Respiratory Failure Treatment
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Cardiopulmonary Machine Market: Competitive Dashboard
14.2 Global Artificial Cardiopulmonary Machine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 LivaNova (Sorin)
14.3.2 Getinge (Maquet)
14.3.3 Medtronic
14.3.4 Terumo CV Group
14.3.5 Braile Biomedica
14.3.6 Tianjin Medical
